Journals / ARTEMİS / 2004 / Cilt: 5 - Sayı: 4

Ovülasyon indüksiyonu ve intrauterin inseminasyon uygulanan infertil çiftlerde misoprostolün gebelik oranları üzerine etkisi

Evaluation of the effects of misoprostol on pregnancy rates among infertile couples undergoing ovulation induction and intrauterine insemination

Journal
ARTEMİS
Pages
299–302
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: In a retrospective analysis involving 34 inseminations in the control group, five pregnancies were recorded for an overall pregnancy rate of 13% per insemination (or cycle).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: In an attempt to improve the conception rates, artificial insemination techniques with misoprostol in various forms have been reported.
📊
Key Findings & Data:The positive effect of vaginal misoprostol leading to an improved clinical pregnancy rate is not clearly understood.
💡
Conclusion & Impact:RESULTS: In a retrospective analysis involving 34 inseminations in the control group, five pregnancies were recorded for an overall pregnancy rate of 13% per insemination (or cycle).
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: In an attempt to improve the conception rates, artificial insemination techniques with misoprostol in various forms have been reported. The positive effect of vaginal misoprostol leading to an improved clinical pregnancy rate is not clearly understood. The known effects of prostaglandin E on increasing myometrial contractility and potential relaxation of tubal isthmus may all facilitate fertilization potential. We intended to investigate here the effects of misoprostol on pregnancy rates and the outcome of intrauterine insemination. MATERIALS-METHODS: All patients (age, ²35 years), whose data on male and female diagnosis was available, were included in the study. The data of 34 cycles, determined as the control group, with either unexplained infertility or ovulatory dysfunction, having undergone therapeutic insemination in an effort to establish pregnancy were retrospectively studied. Prospectively, 33 cycles were randomized as the study group to ovulation induction followed by intrauterine insemination and vaginally administered 200 mg misoprostol at the time of insemination. Oral and injectable fertility drugs were administered. The cycles were monitored and endometrial thickness and follicular development were measured by transvaginal ultrasound. Both retrospective (control group) and prospective (study group) results were reviewed and analyzed and the pregnancy rates in intrauterine insemination recipients were compared. RESULTS: In a retrospective analysis involving 34 inseminations in the control group, five pregnancies were recorded for an overall pregnancy rate of 13% per insemination (or cycle). In the follow-up prospective study (n: 33), four pregnancies were recorded and the pregnancy rate for the intrauterine insemination-misoprostol study group was 11% per cycle. There were two abortions in the misoprostol group while only one recorded in the control group. There was no difference between the couples of the two groups regarding their age; duration, type and cause of infertility.CONCLUSION: Because of the indefinite advantage and the higher miscarriage rates of misoprostol over pure cycles in our study, we cannot recommend presently the routine use of intravaginal misoprostol in intrauterine insemination cycles.

Özet

Amaç: Son zamanlarda gebelik oranlarını artırmak amacıyla farklı formlarda misoprostol ile inseminasyon yöntemleri bildirilmiştir. Henüz olumlu etkisi kesinlik kazanmamış olmasıyla birlikte prostaglandin E'nin myometrial kontraktilite ve tubal istmik relaksasyon üzerine bilinen etkileri nedeniyle fertilizasyonu kolaylaştırabilir. Çalışmamızda bunların gerçekliliğini ispatlamayı ve misoprostolün gebelik oranlan ve ıntrauterin inseminasyon sonuçları üzerine etkilerini araştırmayı planladık. Materyal ve Metot: Yaşı 35 ve altındaki, kadın ve erkeğe ait infertility verileri bulunan tüm olgular materyalimizi oluşturdu. Açıklanamayan infertilite ve ovülasyon disfonksiyonu nedeniyle inseminasyon yapılan toplam 34 siklus kontrol grubu olarak belirlendi ve verileri retrospektif olarak incelendi. Prospektif olarak da 33 siklusa, çalışma grubu olarak belirlendikten sonra, ıntrauterin inseminasyon yapıldı ve inseminasyon sırasında tüm olgulara 200 pg misoprostol intravaginal olarak uygulandı. Ovülasyon indüksiyonu oral ve parenteral yoldan uygulanan ilaçlarla yapıldı. Siklus boyunca endometrial kalınlık ve follikül gelişimi transvaginal ultrasonografi ile monitörize edildi. Retrospektif (kontrol grubu) ve prospektif (çalışma grubu) sonuçlar değerlendirildi ve gebelik oranları karşılaştırıldı. Sonuçlar: Otuz dört inseminasyon içeren retrospektif analizde beş gebelik kaydedildi (inseminasyon veya siklus başına gebelik oranı: %1.3). Otuz üç siklus içeren takip grubunda ise dört gebelik oluştu (siklus başına gebelik oranı: %11). Kontrol grubutula hir düşük görülürken misoprosrol grubunda iki gebelik düşük ile sonuçlandı, iki grup arasında yaş; infertility süresi, tipi ve nedeni açısından fark yoktu. Tartışma: Çalışmamızda, daha yüksek düşük oranları ve saf infrauterin inseminasyon sikluslarına göre üstünlüğünün belirsizliği nedeniyle, intravaginal misoprostolün rutin kullanımını mevcut veriler ışığında önermemekteyiz.

🔖

Cite This Article

İYİBOZKURT, C., ERGUN, B., JAMAL, H., BAYSOY, A., KARTAL, A., DELİER, H. (2022). Ovülasyon indüksiyonu ve intrauterin inseminasyon uygulanan infertil çiftlerde misoprostolün gebelik oranları üzerine etkisi. ARTEMİS, Cilt: 5 - Sayı: 4, 299–302. https://ajindex.com/articles/449488

References (10)

  1. Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod. 1998;13,1553–1558
  2. Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997;12(9):1865-72
  3. Martinez AR, Bernadus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J. A controlled study of human chorionic gonadotrophin induced ovulation versus urinary luteinizing hormone surge for timing of intrauterine insemination. Hum Reprod. 1991;6(9):1247-51
  4. Horne G, Jamaludin A, Critchlow JD, Falconer DA, Newman MC, Oghoetuoma J, Pease EH, Lieberman BA A 3 year retrospective review of intrauterine insemination, using cryopreserved donor spermatozoa and cycle monitoring by urinary or serum luteinizing hormone measurements Hum Reprod. 1998;13:3045-3048
  5. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH, Matulich EM. Relationship of follicle number, serum estradiol, and other factors to birth rate and multiparity in human menopausal gonadotropin-induced intrauterine insemination cycles. Fertil Steril. 1991;56(1):89-92
  6. Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B. Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success Hum Reprod. 1996;11:1892-1896
  7. Ombelet W, Vandeput H, Van de Putte G, Cox A, Janssen M, Jacobs P, Bosmans E, Steeno O, Kruger T. Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology. Hum Reprod. 1997;12:1458-1463
  8. Khalifa Y, Redgment CJ, Tsirigotis M, Grudzinskas JG, Craft IL. The value of single versus repeated insemination in intra-uterine donor insemination cycles. Hum Reprod. 1995;10(1):153-4 9. Barroso G, Karschmer S, Castelazo E, Carballo E, Kably A. A prospective randomized trial of the impact of misoprostol (PGE1) on pregnancy rate after intrauterine insemination (IUI) therapy. Ginecol Obstet Mex, 2001; 69:346-50 10. Coutinho, E.M. and Maia, H.S. The contractile response of the human uterus, fallopian tubes, and ovary to prostaglandins in vivo. Fertil Steril. 1971; 22:539–543
  9. Henzl M.R., Noriega L., Aznar R. et al. The uterine effects of vaginally administered prostaglandin E2. Prostaglandins. 1972;1:205–215
  10. Aitken R.J. and Kelly R.W. Analysis of the direct effects of prostaglandins